Skip to main content
Fig. 5 | BMC Endocrine Disorders

Fig. 5

From: Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study

Fig. 5

Glycemic control in hospitalized patients within 2 weeks of COVID-19 onset blood glucose levels up to day 6 and daily blood glucose levels from days 7 to 13 after COVID-19 onset in patients with known diabetes (blue) and newly diagnosed diabetes (orange). Data are presented as means ± SEM. *P < 0.05 at individual time points. the proportion of patients who experienced sustained hyperglycemia which is defined as an average value of daily blood glucose levels > 200 mg/dl during hospitalization within 13 days of COVID-19 onset in patients with known diabetes (blue) and newly diagnosed diabetes (orange).Abbreviations: DM, diabetes mellitus.

Back to article page